Anavex Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Jun 24 | BuyUS$10,319 | Peter Donhauser | Individual | 2,835 | US$3.64 | |
15 May 24 | BuyUS$22,600 | Steffen Thomas | Individual | 5,000 | US$4.52 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,589,631 | 3.05% |
Institutions | 27,207,656 | 32.1% |
General Public | 54,998,230 | 64.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,740,696 | US$61.4m | 5.46% | no data | |||
4,740,171 | US$43.2m | 4.22% | no data | |||
3,065,947 | US$27.9m | -18% | no data | |||
1,883,199 | US$17.2m | 2.84% | no data | |||
1,306,458 | US$11.9m | 0% | no data | |||
1,250,210 | US$11.4m | 0% | no data | |||
910,476 | US$8.3m | 0% | 0.49% | |||
830,624 | US$7.6m | -18% | 0.02% | |||
695,963 | US$6.3m | 4.01% | no data | |||
665,976 | US$6.1m | 2.29% | no data | |||
546,644 | US$5.0m | 53.5% | no data | |||
493,500 | US$4.5m | -22% | 0.01% | |||
419,589 | US$3.8m | 54.2% | no data | |||
370,400 | US$3.4m | 0% | 0.09% | |||
340,986 | US$3.1m | 802% | no data | |||
298,966 | US$2.7m | 81.1% | no data | |||
275,095 | US$2.5m | -54.2% | no data | |||
243,800 | US$2.2m | -47.7% | no data | |||
238,417 | US$2.2m | -9.84% | no data | |||
224,980 | US$2.0m | -19.8% | no data | |||
178,965 | US$1.6m | -40.9% | no data | |||
155,179 | US$1.4m | 70.4% | no data | |||
139,586 | US$1.3m | -37.8% | no data | |||
136,596 | US$1.2m | 202% | no data | |||
130,057 | US$1.2m | -8.82% | no data |